Biochemical effects of Piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C
Philipp Saiko(Ludwig Boltzmann Institute Applied Diagnostics), Thomas Szekeres(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Walter Jaeger(University of Vienna), Michael Grusch(Comprehensive Cancer Center Vienna), Astrid Bernhaus(Vienna General Hospital), Mária Ozsvár-Kozma(Medical University of Vienna), Monika Fritzer‐Szekeres(Vienna General Hospital), Ivo Savinc(Medical University of Vienna)
Cancer Research
April 15, 2006
Cited by 17
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303